Properties of a cytopathic agent isolated from a patient with subacute sclerosing panencephalitis in Japan.
D000818:Animals; D001706:Biopsy; D001921:Brain / Q000382:microbiology; D001973:Bromodeoxyuridine / Q000494:pharmacology; D002460:Cell Line; D002469:Cell Separation; D002474:Cell-Free System; D002478:Cells, Cultured; D002648:Child; D006224:Cricetinae; D003588:Cytopathogenic Effect, Viral; D003609:Dactinomycin / Q000494:pharmacology; D005260:Female; D005455:Fluorescent Antibody Technique; D005615:Freezing; D006168:Guinea Pigs; D000882:Haplorhini; D006801:Humans; D007106:Immune Sera; D007564:Japan; D007668:Kidney; D008459:Measles virus / Q000254:growth & development; D051379:Mice; D008854:Microscopy, Electron; D027383:Papillomaviridae / Q000254:growth & development / Q000302:isolation & purification; D017955:Poliovirus / Q000254:growth & development; D027382:Polyomaviridae; D011309:Preservation, Biological; D011817:Rabbits / Q000276:immunology; D013344:Subacute Sclerosing Panencephalitis / Q000276:immunology / Q000382:microbiology*; D010948:Viral Plaque Assay
D007106:Immune Sera; D003609:Dactinomycin; D001973:Bromodeoxyuridine